The development of a project for a new
pharmaceutical manufacturing plant with our
consultants will allow you having a plant with an
appropriate design to fulfill GMP requirements and
minimise risks of contamination as well as meeting
the current qualification and validation standards.
About this Case Study
An international pharmaceutical company in Portugal expanded its operations with a new solid dosage form plant to serve the EU and US markets. The project involved establishing a Validation Master Plan, reviewing GMP compliance, and implementing qualification protocols for equipment, utilities, and cleaning methods. The facility was designed to minimise contamination risks and ensure GMP compliance, meeting both local and international regulatory standards.
Discover how our consultants helped streamline the process and ensure seamless project delivery—read more to see how we supported the client in achieving their goals.
Download the Case Study
View other our other resources and company news
Blog Why Quality Management Maturity (QMM) Is the Future of Pharmaceutical Compliance
Case Study Validating an S/4 HANA ERP Upgrade for Medical Device Compliance
Blog EMA Updates Guidance on Third-Party GMP Audits: Rephine Strengthens Conflict of Interest Controls
Guide Medical Device Software Testing for MDR/IVDR Compliance | Rephine Guide
Case Study Implementing a Site-Wide CPV Strategy to Strengthen Process Control
Blog Continued Process Verification (CPV) in GMP Manufacturing
Medical Device The Artificial Intelligence Act (EU 2024/1689) Whitepaper: Key Obligations, Risks, and Compliance
Guide When Does Medical Software Qualify as a Medical Device? | MDR & IVDR Guide
Case Study